Document is current
Any future updates will be listed below
-
Authors
Wu, Jingjing
Deng, Yuan
Gao, Yong
Wei, Bin
-
Funding
Funding for this research was provided by:
Huai'an Natural Science Research Program (HAB202205)
Young Innovative Talent Program of Huai’an First People’s Hospital (QC202213)
National Natural Science Foundation of China (82103318)
Innovation key Talent Program of Huai’an First People’s Hospital (ZC202201)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 6 August 2025
First Online: 25 August 2025
Declarations
:
: The authors declare that they have no conflicts of interest to this work. Graphical abstract was created by Figdraw ().
: The use of human tumor specimens was approved by the Ethics Committee of the Odo Biotechnology Company (ethical number: SHYJS-BC-2310001). The animal research protocol was approved by the Ethics Committee of the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University (ethical number: DW-Y-2024-025-01)
